HCA vs NVS
HCA: HCA Healthcare is one of the nation's largest operators of acute care hospitals and related health services, leveraging a massive footprint to provide comprehensive medical care. NVS: Global pharmaceutical and biotechnology company pioneering disease-modifying treatments across oncology, immunology, neuroscience, and rare genetic diseases.
Side-by-side fundamentals
| Metric | HCA | NVS | Edge |
|---|---|---|---|
| Price as of 2026-07-31 close | $402.59 | $156.11 | |
| Market cap as of 2026-08-03 | $89.3B | $232.1B | |
| P/E as of 2026-08-03 | 13.85 | 22.53 | HCA lower |
| PEG as of 2026-08-03 | 1.39 | 3.66 | HCA lower |
| Net margin as of 2026-08-03 | +8.9% | +22.5% | NVS higher |
| Gross margin as of 2026-08-03 | +85.0% | +75.0% | HCA higher |
| Operating margin as of 2026-08-03 | +15.7% | +29.9% | NVS higher |
| ROE as of 2026-08-03 | +695.7% | +29.9% | HCA higher |
| ROA as of 2026-08-03 | +11.3% | +11.1% | HCA higher |
| Debt / equity as of 2026-08-03 | 125.80 | 1.18 | NVS lower |
| Revenue growth (YoY) as of 2026-08-03 | +6.7% | +3.3% | HCA higher |
| Revenue CAGR (3y) SEC XBRL | +7.9% | n/a | |
| Dividend yield as of 2026-08-03 | +0.8% | +2.9% | NVS higher |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-08-03 | 0.26 | 1.17 | |
| 1-year return as of 2026-07-31 close | +13.7% | +32.6% | NVS higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-31.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.